CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Sanofi-Aventis U.S. LLC v. Zydus Pharmaceuticals (USA) Inc.

1:17-cv-00034

Overview

Case Number 1:17-cv-00034
Filing Date 2017-01-11
Status Terminated
Termination Date 2018-01-02
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Cadila Healthcare Limited NPE (University / Research)

Represented By

2 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Zydus Pharmaceuticals (USA) Inc. Operating Company

Represented By

3 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Nina Vachhani

Email: nvachhani@lockelord.com

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Plaintiff

Genzyme Corporation NPE (Individual / Inventor)

Represented By

7 Attorneys Listed

Paula S. Fritsch

Email: pfritsch@amgen.com

Paul H. Berghoff

Email: berghoff@mbhb.com

Karen Riesenburger Poppel

RatnerPrestia, P.C.

Tel: +1 (302) 778-2500

1007 Orange Street, Suite 205, P.O. Box 1596

Brandon J. Kennedy

Email: kennedy@mbhb.com

Ann C. Palma

Email: palma@mbhb.com

Alison J. Baldwin

Email: baldwin@mbhb.com

Jeffrey B. Bove

RatnerPrestia, P.C.

Tel: +1 (302) 778-2500

1007 Orange Street, Suite 205, P.O. Box 1596

Sanofi Operating Company

Represented By

7 Attorneys Listed

Paula S. Fritsch

Email: pfritsch@amgen.com

Paul H. Berghoff

Email: berghoff@mbhb.com

Karen Riesenburger Poppel

RatnerPrestia, P.C.

Tel: +1 (302) 778-2500

1007 Orange Street, Suite 205, P.O. Box 1596

Brandon J. Kennedy

Email: kennedy@mbhb.com

Ann C. Palma

Email: palma@mbhb.com

Alison J. Baldwin

Email: baldwin@mbhb.com

Jeffrey B. Bove

RatnerPrestia, P.C.

Tel: +1 (302) 778-2500

1007 Orange Street, Suite 205, P.O. Box 1596

Aventisub LLC Operating Company

Represented By

7 Attorneys Listed

Paula S. Fritsch

Email: pfritsch@amgen.com

Paul H. Berghoff

Email: berghoff@mbhb.com

Karen Riesenburger Poppel

RatnerPrestia, P.C.

Tel: +1 (302) 778-2500

1007 Orange Street, Suite 205, P.O. Box 1596

Brandon J. Kennedy

Email: kennedy@mbhb.com

Ann C. Palma

Email: palma@mbhb.com

Alison J. Baldwin

Email: baldwin@mbhb.com

Jeffrey B. Bove

RatnerPrestia, P.C.

Tel: +1 (302) 778-2500

1007 Orange Street, Suite 205, P.O. Box 1596

Sanofi-Aventis U.S. LLC Operating Company

Represented By

7 Attorneys Listed

Paula S. Fritsch

Email: pfritsch@amgen.com

Paul H. Berghoff

Email: berghoff@mbhb.com

Karen Riesenburger Poppel

RatnerPrestia, P.C.

Tel: +1 (302) 778-2500

1007 Orange Street, Suite 205, P.O. Box 1596

Brandon J. Kennedy

Email: kennedy@mbhb.com

Ann C. Palma

Email: palma@mbhb.com

Alison J. Baldwin

Email: baldwin@mbhb.com

Jeffrey B. Bove

RatnerPrestia, P.C.

Tel: +1 (302) 778-2500

1007 Orange Street, Suite 205, P.O. Box 1596

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): 🇪🇺 Europe 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9186346
Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients
Filed: 2014-02-04
Issued: 2015-11-17
Active (7.2 yrs remaining)
Expires: 2034-02-04
US8802735
(Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
Filed: 2012-03-16
Issued: 2014-08-12
Active (5.3 yrs remaining)
Expires: 2032-03-16

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 2 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending
ORAL ORDER re (21 in 1:16-cv-01298-GMS, 21 in 1:17-cv-00024-GMS, 19 in 1:17-cv-00027-GMS, 16 in 1:17-cv-00003-GMS, 21 in 1:17-cv-00018-GMS, 17 in 1:17-cv-00019-...
Entry #— • 2017-06-13
Procedural / Extension Motion Pending
SO ORDERED, re 8 STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to April 10, 2017 filed by Aventisub LLC, Genzyme Corporation, San...
Entry #— • 2017-03-31
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to April 10, 2017 - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Ave...
Entry #8 • 2017-03-30 Document →

Docket Entries

(44 total)
Pleading / Complaint

COMPLAINT filed against Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2063294.) - filed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(sar) (Entered: 01/12/2017)

Entry #1 • 2017-01-11
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 01/12/2017)

Entry #2 • 2017-01-11
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 29, 2016. Date of Expiration of Patent: US 9,186,346 - Feb. 4, 2034; US 8,802,735 - Sept. 14, 2030.Thirty Month Stay Deadline: 5/29/2019. (sar) (Entered: 01/12/2017)

Entry #3 • 2017-01-11
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,802,735 B2; US 9,186,346 B2;. (sar) (Entered: 01/12/2017)

Entry #4 • 2017-01-11
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Aventisub LLC, Genzyme Corporation, Sanofi-Aventis U.S. LLC filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 01/12/2017)

Entry #5 • 2017-01-12
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc